Skip to main content
OpenTrials
Completed

NCT Number: NCT07429201

Comparing an Electrolyte-Carbohydrate Beverage to Water During Ramadan

The purpose of this study is to explore the effects of breaking the fast (iftar) during Ramadan with different beverages on dietary and beverage intake patterns and related measurements during the hours after iftar and into the next morning, as well as participants' self-reported feelings such as thirst, mood, and overall wellbeing.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year–50 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Safa Pioneer Clinic, Amna Bint Wahb St.

Jeddah, Al Mohammadiyyah, 23623, Saudi Arabia

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Healthy Muslim adults aged 18-50 years who are observing Ramadan fasting.
  • Able and willing to provide written informed consent.
  • Able to speak, read, and understand Arabic or English sufficiently to comply with study procedures.
  • Willing and able to consume the electrolyte-carbohydrate (EC) beverage and water during study visits.
  • Demonstrates product acceptability during screening, defined as overall liking (OL) score ≥ 6 following consumption of a 50 mL sample of the EC beverage (9-point hedonic scale).
  • Self-reported as generally healthy with no known condition that would interfere with participation.
  • Able to comply with study procedures and attend two on-site intervention visits.
  • Willing and able to maintain usual daytime sleep patterns during the intervention period (i.e., avoid intentional major changes to sleep schedule) from 48 hours prior to each intervention visit until the following morning assessment.

Exclusion criteria

  • Any medical condition or medication use known to affect fluid balance/hydration status, including but not limited to diuretics, laxatives, weight-loss medications.
  • History of clinically significant cardiovascular, renal, endocrine, or metabolic disease.
  • Pregnant or breastfeeding (lactating) females, or females who plan to become pregnant during the study period.
  • Engagement in heavy/vigorous exercise within 24 hours prior to any study visit.
  • Participation in any PepsiCo-sponsored clinical trial within the previous 6 months.
  • Participation in any other interventional clinical trial within the previous 30 days.

Treatment and study plan

Witnessed ad libitum electrolyte-carbohydrate beverage intake over 120 minutes

Other

Participants will consume the study electrolyte-carbohydrate beverage ad libitum over a 120-minute period following Iftar under supervised conditions. No other foods or beverages will be permitted during the first 120 minutes.

Witnessed ad libitum water intake over 120 minutes

Other

Participants will consume water ad libitum over a 120-minute period following Iftar under supervised conditions. No other foods or beverages will be permitted during the first 120 minutes.

Primary outcomes

  1. To compare post-fast fluid intake when breaking the fast with an Electrolyte-Carbohydrate beverage versus water

    Time frame: From iftar to 120 minutes

    Total volume consumed in milliliters

Secondary outcomes

  1. To characterize habitual fluid intake patterns before Ramadan using 24-hour dietary recall

    Time frame: 24 hour period prior to Ramadan fasting

    Measured for usual non-fasting day

  2. To characterize habitual fluid intake patterns during Ramadan using 24-hour dietary recall

    Time frame: 24 hour period during Ramadan fasting

    Measured for a usual fasting day

Sponsors and collaborators

Lead sponsor

PepsiCo Global R&D

Industry

Registry information

Official study title

A Randomized, Open-Label, Crossover Study Comparing an Electrolyte-Carbohydrate Beverage to Water During Ramadan

Important dates

Study start
2026
Primary completion
2026
Study completion
2026
First posted
Feb 24, 2026
Registry last updated
Mar 17, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.